{"frames":[{"target":{"name":"Frequency","spans":[{"start":0,"end":1,"text":"Annual"}]},"annotationSets":[{"rank":0,"score":32.44726627751411,"frameElements":[{"name":"Event","spans":[{"start":1,"end":2,"text":"review"}]},{"name":"Interval","spans":[{"start":0,"end":1,"text":"Annual"}]}]}]},{"target":{"name":"Medical_specialties","spans":[{"start":3,"end":4,"text":"medicine"}]},"annotationSets":[{"rank":0,"score":5.190858220391284,"frameElements":[{"name":"Specialty","spans":[{"start":3,"end":4,"text":"medicine"}]}]}]}],"tokens":["Annual","review","of","medicine",",","vol","66","."]}
{"frames":[{"target":{"name":"Aiming","spans":[{"start":0,"end":1,"text":"Targeting"}]},"annotationSets":[{"rank":0,"score":40.176745582356226,"frameElements":[]}]},{"target":{"name":"Cure","spans":[{"start":4,"end":5,"text":"Treatment"}]},"annotationSets":[{"rank":0,"score":44.88477299282848,"frameElements":[]}]},{"target":{"name":"Observable_body_parts","spans":[{"start":6,"end":7,"text":"Breast"}]},"annotationSets":[{"rank":0,"score":25.285646904066255,"frameElements":[{"name":"Body_part","spans":[{"start":6,"end":7,"text":"Breast"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":7,"end":8,"text":"Cancer"}]},"annotationSets":[{"rank":0,"score":35.49841662521993,"frameElements":[]}]}],"tokens":["Targeting","HER2","for","the","Treatment","of","Breast","Cancer","."]}
{"frames":[{"target":{"name":"Membership","spans":[{"start":6,"end":7,"text":"member"}]},"annotationSets":[{"rank":0,"score":11.918255664427935,"frameElements":[{"name":"Member","spans":[{"start":6,"end":7,"text":"member"}]},{"name":"Group","spans":[{"start":7,"end":15,"text":"of the HER family of tyrosine kinase receptors"}]}]}]},{"target":{"name":"Kinship","spans":[{"start":10,"end":11,"text":"family"}]},"annotationSets":[{"rank":0,"score":19.191195806693912,"frameElements":[{"name":"Relatives","spans":[{"start":10,"end":11,"text":"family"}]}]}]},{"target":{"name":"Importance","spans":[{"start":21,"end":22,"text":"major"}]},"annotationSets":[{"rank":0,"score":53.295482551609,"frameElements":[{"name":"Factor","spans":[{"start":22,"end":23,"text":"driver"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":24,"end":25,"text":"tumor"}]},"annotationSets":[{"rank":0,"score":31.409946575682167,"frameElements":[]}]},{"target":{"name":"Change_position_on_a_scale","spans":[{"start":25,"end":26,"text":"growth"}]},"annotationSets":[{"rank":0,"score":110.43160563834728,"frameElements":[]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":27,"end":28,"text":"20"}]},"annotationSets":[{"rank":0,"score":30.12789472234158,"frameElements":[{"name":"Number","spans":[{"start":27,"end":28,"text":"20"}]},{"name":"Entity","spans":[{"start":28,"end":32,"text":"% of breast cancers"}]}]}]},{"target":{"name":"Observable_body_parts","spans":[{"start":30,"end":31,"text":"breast"}]},"annotationSets":[{"rank":0,"score":24.724328733922956,"frameElements":[{"name":"Body_part","spans":[{"start":30,"end":31,"text":"breast"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":31,"end":32,"text":"cancers"}]},"annotationSets":[{"rank":0,"score":40.03940138308876,"frameElements":[]}]}],"tokens":["HER2","-LRB-","ErbB2","-RRB-",",","a","member","of","the","HER","family","of","tyrosine","kinase","receptors","-LRB-","HER1-4","-RRB-",",","is","a","major","driver","of","tumor","growth","in","20","%","of","breast","cancers","."]}
{"frames":[{"target":{"name":"Cure","spans":[{"start":0,"end":1,"text":"Treatment"}]},"annotationSets":[{"rank":0,"score":45.924488030112315,"frameElements":[]}]},{"target":{"name":"Observable_body_parts","spans":[{"start":16,"end":17,"text":"breast"}]},"annotationSets":[{"rank":0,"score":24.86550922762732,"frameElements":[{"name":"Body_part","spans":[{"start":16,"end":17,"text":"breast"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":17,"end":18,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":34.25231905725022,"frameElements":[{"name":"Ailment","spans":[{"start":17,"end":18,"text":"cancer"}]}]}]}],"tokens":["Treatment","with","the","anti-HER2","monoclonal","antibody","trastuzumab","has","revolutionized","the","outcome","of","patients","with","this","aggressive","breast","cancer","subtype",",","but","intrinsic","and","acquired","resistance","is","common","."]}
{"frames":[{"target":{"name":"Expansion","spans":[{"start":0,"end":1,"text":"Growing"}]},"annotationSets":[{"rank":0,"score":41.06297931993291,"frameElements":[{"name":"Item","spans":[{"start":1,"end":17,"text":"understanding of the biology and complexity of the HER2 signaling network and of potential resistance mechanisms"}]}]}]},{"target":{"name":"Awareness","spans":[{"start":1,"end":2,"text":"understanding"}]},"annotationSets":[{"rank":0,"score":50.963152500976875,"frameElements":[{"name":"Content","spans":[{"start":2,"end":17,"text":"of the biology and complexity of the HER2 signaling network and of potential resistance mechanisms"}]},{"name":"Degree","spans":[{"start":0,"end":1,"text":"Growing"}]}]}]},{"target":{"name":"Network","spans":[{"start":11,"end":12,"text":"network"}]},"annotationSets":[{"rank":0,"score":23.72962580266155,"frameElements":[{"name":"Network","spans":[{"start":11,"end":12,"text":"network"}]}]}]},{"target":{"name":"Capability","spans":[{"start":14,"end":15,"text":"potential"}]},"annotationSets":[{"rank":0,"score":37.20136971892169,"frameElements":[]}]},{"target":{"name":"Means","spans":[{"start":16,"end":17,"text":"mechanisms"}]},"annotationSets":[{"rank":0,"score":17.55039086260738,"frameElements":[{"name":"Means","spans":[{"start":16,"end":17,"text":"mechanisms"}]},{"name":"Purpose","spans":[{"start":15,"end":16,"text":"resistance"}]}]}]},{"target":{"name":"Cotheme","spans":[{"start":18,"end":19,"text":"guided"}]},"annotationSets":[{"rank":0,"score":88.7830033299031,"frameElements":[{"name":"Theme","spans":[{"start":19,"end":25,"text":"the development of new HER2-targeted agents"}]}]}]},{"target":{"name":"Event","spans":[{"start":20,"end":21,"text":"development"}]},"annotationSets":[{"rank":0,"score":36.332273492176185,"frameElements":[{"name":"Event","spans":[{"start":19,"end":25,"text":"the development of new HER2-targeted agents"}]}]}]},{"target":{"name":"Age","spans":[{"start":22,"end":23,"text":"new"}]},"annotationSets":[{"rank":0,"score":44.2099965586366,"frameElements":[{"name":"Age","spans":[{"start":22,"end":23,"text":"new"}]},{"name":"Entity","spans":[{"start":24,"end":25,"text":"agents"}]}]}]},{"target":{"name":"People_by_vocation","spans":[{"start":24,"end":25,"text":"agents"}]},"annotationSets":[{"rank":0,"score":56.092944606159264,"frameElements":[{"name":"Person","spans":[{"start":24,"end":25,"text":"agents"}]}]}]}],"tokens":["Growing","understanding","of","the","biology","and","complexity","of","the","HER2","signaling","network","and","of","potential","resistance","mechanisms","has","guided","the","development","of","new","HER2-targeted","agents","."]}
{"frames":[{"target":{"name":"Intoxicants","spans":[{"start":3,"end":4,"text":"drugs"}]},"annotationSets":[{"rank":0,"score":20.82737087790249,"frameElements":[{"name":"Intoxicant","spans":[{"start":3,"end":4,"text":"drugs"}]}]}]},{"target":{"name":"Increment","spans":[{"start":5,"end":6,"text":"more"}]},"annotationSets":[{"rank":0,"score":15.644647935682187,"frameElements":[{"name":"Class","spans":[{"start":6,"end":7,"text":"completely"}]}]}]},{"target":{"name":"Hindering","spans":[{"start":7,"end":8,"text":"inhibit"}]},"annotationSets":[{"rank":0,"score":49.37010154784922,"frameElements":[{"name":"Degree","spans":[{"start":5,"end":7,"text":"more completely"}]}]}]},{"target":{"name":"Cause_to_amalgamate","spans":[{"start":14,"end":15,"text":"combining"}]},"annotationSets":[{"rank":0,"score":46.848324587998434,"frameElements":[]}]},{"target":{"name":"People_by_vocation","spans":[{"start":16,"end":17,"text":"agents"}]},"annotationSets":[{"rank":0,"score":53.88026448241745,"frameElements":[{"name":"Person","spans":[{"start":16,"end":17,"text":"agents"}]}]}]},{"target":{"name":"People_by_vocation","spans":[{"start":18,"end":19,"text":"agents"}]},"annotationSets":[{"rank":0,"score":62.39103232126908,"frameElements":[{"name":"Person","spans":[{"start":18,"end":19,"text":"agents"}]}]}]},{"target":{"name":"Purpose","spans":[{"start":20,"end":21,"text":"target"}]},"annotationSets":[{"rank":0,"score":33.18004967856082,"frameElements":[{"name":"Goal","spans":[{"start":18,"end":19,"text":"agents"}]},{"name":"Agent","spans":[{"start":19,"end":20,"text":"that"}]}]}]},{"target":{"name":"Roadways","spans":[{"start":25,"end":26,"text":"pathways"}]},"annotationSets":[{"rank":0,"score":73.33174274370143,"frameElements":[{"name":"Roadway","spans":[{"start":25,"end":26,"text":"pathways"}]}]}]},{"target":{"name":"Ingredients","spans":[{"start":28,"end":29,"text":"components"}]},"annotationSets":[{"rank":0,"score":32.23739397969056,"frameElements":[{"name":"Material","spans":[{"start":28,"end":29,"text":"components"}]},{"name":"Product","spans":[{"start":29,"end":34,"text":"of the host immune system"}]}]}]},{"target":{"name":"Aggregate","spans":[{"start":31,"end":32,"text":"host"}]},"annotationSets":[{"rank":0,"score":27.145370620503765,"frameElements":[{"name":"Aggregate","spans":[{"start":31,"end":32,"text":"host"}]}]}]},{"target":{"name":"Gizmo","spans":[{"start":33,"end":34,"text":"system"}]},"annotationSets":[{"rank":0,"score":20.549381780218184,"frameElements":[{"name":"Use","spans":[{"start":32,"end":33,"text":"immune"}]}]}]},{"target":{"name":"Scrutiny","spans":[{"start":38,"end":39,"text":"investigated"}]},"annotationSets":[{"rank":0,"score":51.77850063016366,"frameElements":[{"name":"Ground","spans":[{"start":39,"end":45,"text":"in the preclinical and clinical settings"}]}]}]}],"tokens":["Combinations","of","these","drugs","to","more","completely","inhibit","the","HER","receptor","layer",",","or","combining","HER2-targeted","agents","with","agents","that","target","downstream","signaling",",","alternative","pathways",",","or","components","of","the","host","immune","system",",","are","being","vigorously","investigated","in","the","preclinical","and","clinical","settings","."]}
{"frames":[{"target":{"name":"Causation","spans":[{"start":2,"end":3,"text":"result"}]},"annotationSets":[{"rank":0,"score":67.23751508784405,"frameElements":[]}]},{"target":{"name":"Text","spans":[{"start":5,"end":6,"text":"list"}]},"annotationSets":[{"rank":0,"score":51.021093644040405,"frameElements":[{"name":"Text","spans":[{"start":5,"end":6,"text":"list"}]},{"name":"Author","spans":[{"start":0,"end":3,"text":"As a result"}]}]}]},{"target":{"name":"Increment","spans":[{"start":7,"end":8,"text":"more"}]},"annotationSets":[{"rank":0,"score":14.635248739352285,"frameElements":[{"name":"Added_set","spans":[{"start":7,"end":8,"text":"more"}]}]}]},{"target":{"name":"Usefulness","spans":[{"start":8,"end":9,"text":"effective"}]},"annotationSets":[{"rank":0,"score":27.436581976072077,"frameElements":[{"name":"Entity","spans":[{"start":4,"end":8,"text":"the list of more"}]}]}]},{"target":{"name":"Tolerating","spans":[{"start":11,"end":12,"text":"tolerated"}]},"annotationSets":[{"rank":0,"score":6.614524973168043,"frameElements":[{"name":"Content","spans":[{"start":12,"end":15,"text":"FDA-approved new regimens"}]},{"name":"Experiencer","spans":[{"start":4,"end":8,"text":"the list of more"}]}]}]},{"target":{"name":"Age","spans":[{"start":13,"end":14,"text":"new"}]},"annotationSets":[{"rank":0,"score":45.19854583927496,"frameElements":[{"name":"Age","spans":[{"start":13,"end":14,"text":"new"}]},{"name":"Entity","spans":[{"start":14,"end":15,"text":"regimens"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":19,"end":20,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":34.09177703115916,"frameElements":[]}]},{"target":{"name":"Frequency","spans":[{"start":21,"end":22,"text":"constantly"}]},"annotationSets":[{"rank":0,"score":32.27911696382151,"frameElements":[]}]},{"target":{"name":"Expansion","spans":[{"start":22,"end":23,"text":"growing"}]},"annotationSets":[{"rank":0,"score":39.96634476319124,"frameElements":[{"name":"Item","spans":[{"start":4,"end":8,"text":"the list of more"}]}]}]}],"tokens":["As","a","result",",","the","list","of","more","effective","and","well","tolerated","FDA-approved","new","regimens","for","patients","with","HER2+","tumors","is","constantly","growing","."]}
